These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 33884099)
21. [Using carnosine and natural antioxidants for the prophylaxis of acute post-loading oxidative stress]. Rozhkova EA; Ordzhonikidze ZG; Druzhinin AE; Seĭfulla NR; Paniushkin VV; Kuznetsov IuM Eksp Klin Farmakol; 2007; 70(5):44-6. PubMed ID: 18074807 [TBL] [Abstract][Full Text] [Related]
22. Current antioxidant molecular therapies for oxidative stress-related ailments. Ramos-Márquez ME; Siller-López F Curr Gene Ther; 2008 Aug; 8(4):256-63. PubMed ID: 18691021 [TBL] [Abstract][Full Text] [Related]
23. The Potential for Natural Antioxidant Supplementation in the Early Stages of Neurodegenerative Disorders. Oppedisano F; Maiuolo J; Gliozzi M; Musolino V; Carresi C; Nucera S; Scicchitano M; Scarano F; Bosco F; Macrì R; Ruga S; Zito MC; Palma E; Muscoli C; Mollace V Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32283806 [TBL] [Abstract][Full Text] [Related]
24. Berberine and neurodegeneration: A review of literature. Ahmed T; Gilani AU; Abdollahi M; Daglia M; Nabavi SF; Nabavi SM Pharmacol Rep; 2015 Oct; 67(5):970-9. PubMed ID: 26398393 [TBL] [Abstract][Full Text] [Related]
26. Therapeutic antioxidants for neurodegenerative disease. Linseman DA Recent Pat CNS Drug Discov; 2012 Dec; 7(3):183. PubMed ID: 22857712 [No Abstract] [Full Text] [Related]
27. Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment. Halliwell B Drugs Aging; 2001; 18(9):685-716. PubMed ID: 11599635 [TBL] [Abstract][Full Text] [Related]
28. The discovery and development of new potential antioxidant agents for the treatment of neurodegenerative diseases. Danta CC; Piplani P Expert Opin Drug Discov; 2014 Oct; 9(10):1205-22. PubMed ID: 25056182 [TBL] [Abstract][Full Text] [Related]
29. Applications of Antioxidants in Metabolic Disorders and Degenerative Diseases: Mechanistic Approach. Abdel-Daim MM; El-Tawil OS; Bungau SG; Atanasov AG Oxid Med Cell Longev; 2019; 2019():4179676. PubMed ID: 31467632 [No Abstract] [Full Text] [Related]
30. Neuroprotection against oxidative injury by a nucleic acid-based health product (Squina DNA) through enhancing mitochondrial antioxidant status and functional capacity. Lam PY; Chen N; Chiu PY; Leung HY; Ko KM J Med Food; 2012 Jul; 15(7):629-38. PubMed ID: 22612294 [TBL] [Abstract][Full Text] [Related]
31. Oxidative stress and neurodegenerative disorders. Sun AY; Chen YM J Biomed Sci; 1998; 5(6):401-14. PubMed ID: 9845843 [TBL] [Abstract][Full Text] [Related]
32. [Oxidative stress and natural antioxidant mechanisms: the role in neurodegeneration. From molecular mechanisms to therapeutic strategies]. Karpińska A; Gromadzka G Postepy Hig Med Dosw (Online); 2013 Jan; 67():43-53. PubMed ID: 23475482 [TBL] [Abstract][Full Text] [Related]
33. Potential of Naturally Derived Alkaloids as Multi-Targeted Therapeutic Agents for Neurodegenerative Diseases. Kong YR; Tay KC; Su YX; Wong CK; Tan WN; Khaw KY Molecules; 2021 Jan; 26(3):. PubMed ID: 33573300 [TBL] [Abstract][Full Text] [Related]
34. Natural product-derived pharmacological modulators of Nrf2/ARE pathway for chronic diseases. Kumar H; Kim IS; More SV; Kim BW; Choi DK Nat Prod Rep; 2014 Jan; 31(1):109-39. PubMed ID: 24292194 [TBL] [Abstract][Full Text] [Related]
35. How can we target oxidative stress in the treatment of neurodegenerative diseases? Akasaka H; Ruan KH Future Med Chem; 2016 May; 8(8):835-9. PubMed ID: 27173453 [No Abstract] [Full Text] [Related]
36. Hybrid molecules incorporating natural products: applications in cancer therapy, neurodegenerative disorders and beyond. Decker M Curr Med Chem; 2011; 18(10):1464-75. PubMed ID: 21428895 [TBL] [Abstract][Full Text] [Related]
38. Antioxidant effects of curcumin in models of neurodegeneration, aging, oxidative and nitrosative stress: A review. Abrahams S; Haylett WL; Johnson G; Carr JA; Bardien S Neuroscience; 2019 May; 406():1-21. PubMed ID: 30825584 [TBL] [Abstract][Full Text] [Related]
39. [Idebenone (noben) -- from theory to practice]. Rachin AP; Averchenkova AA Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(5):81-4. PubMed ID: 21666596 [No Abstract] [Full Text] [Related]
40. Natural Products: Optimizing Cancer Treatment through Modulation of Redox Balance. Rijo P; Pešić M; Fernandes AS; Santos CN Oxid Med Cell Longev; 2020; 2020():2407074. PubMed ID: 32566077 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]